These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2601000)

  • 41. Digitoxin antibody cross-reactivity and evaluation of potential candidates for circulating digitalis-like immunoreactive factor.
    Graves SW; Naomi S; Williams GH; Hollenberg NK
    Clin Chem; 1994 Oct; 40(10):1977-8. PubMed ID: 7923784
    [No Abstract]   [Full Text] [Related]  

  • 42. Methods for eliminating interferences in digoxin immunoassays caused by digoxin-like factors.
    Graves SW; Sharma K; Chandler AB
    Clin Chem; 1986 Aug; 32(8):1506-9. PubMed ID: 3755385
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Atrial natriuretic factor, digoxin-like immunoreactive substance, norepinephrine, epinephrine, and plasma renin activity in human fetuses and their alteration by fetal disease.
    Weiner CP; Robillard JE
    Am J Obstet Gynecol; 1988 Dec; 159(6):1353-60. PubMed ID: 2974684
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of digoxin-like immunoreactive substances on the "Dac-Cel" digoxin assay.
    Smith RL
    Clin Chem; 1987 Sep; 33(9):1697. PubMed ID: 3621591
    [No Abstract]   [Full Text] [Related]  

  • 45. Malignant immunoblastic lymphoma complicated by IgM gammopathy and digoxin-like immunoreactive substance.
    Ng JP; Green ST; McGovern E; Horn EM; Whiting B; Cumming RL; Hogg RB
    Clin Lab Haematol; 1987; 9(4):421-3. PubMed ID: 3442977
    [No Abstract]   [Full Text] [Related]  

  • 46. Pharmacological actions of "kyushin," a drug containing toad venom (3): Effects on experimentally induced arrhythmia.
    Morishita S; Sugimoto C; Shoji M; Hirai Y; Oguni Y; Ito C; Higuchi M; Sakanashi M
    Am J Chin Med; 1993; 21(2):139-49. PubMed ID: 8237891
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Digoxin-like immunoreactive substance in renal failure: a reappraisal.
    Greenway DC; Nanji AA
    Nephron; 1986; 44(2):108-10. PubMed ID: 3774074
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Digoxin-like immunoreactive factor and premature labour.
    Goodlin RC
    Lancet; 1987 Jan; 1(8524):102-3. PubMed ID: 2879153
    [No Abstract]   [Full Text] [Related]  

  • 49. Digoxin-like immunoreactive substances in urine and serum from preterm and term infants: relationship to renal excretion of sodium.
    Ebara H; Suzuki S; Nagashima K; Shimano S; Kuroume T
    J Pediatr; 1986 May; 108(5 Pt 1):760-2. PubMed ID: 3009770
    [No Abstract]   [Full Text] [Related]  

  • 50. Digoxinlike immunoreactive substance in critically ill patients.
    Berendes E; Walter M; Prien T; Assmann G; Lawin P
    Anesthesiology; 1994 Jun; 80(6):1408-9. PubMed ID: 8010494
    [No Abstract]   [Full Text] [Related]  

  • 51. Digoxin-like immunoreactive substance: monoclonal and polyclonal RIA and FPIA compared.
    Mojaverian P; Green PJ; Jhangiania RK; Chase GD
    J Pharm Biomed Anal; 1989; 7(5):585-92. PubMed ID: 2490762
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Digoxin radioimmunoassay that does not detect digoxin-like substance in serum of newborns, infants, or patients with renal failure.
    Witherspoon L; Shuler S; Neely H; Sonnemaker R; Alyea K; Gilbert S
    Clin Chem; 1987 Mar; 33(3):420. PubMed ID: 3815819
    [No Abstract]   [Full Text] [Related]  

  • 53. Interference from digoxin-like immunoreactive substance(s) in commercial digoxin kit assay methods.
    Morris RG; Frewin DB; Saccoia NC; Goldsworthy WL; Jeffries WS; McPhee AJ
    Eur J Clin Pharmacol; 1990; 39(4):359-63. PubMed ID: 2076718
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endogenous digoxin-like factor contributes to the elevation of systemic resistance in rats exposed to high salt intake from prepuberty.
    Zicha J; Kunes J; Stolba P
    J Hypertens Suppl; 1985 Dec; 3(3):S17-9. PubMed ID: 2856698
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Changes in plasma and urinary digoxin-immunoreactive like substance in normal pregnancy and pregnancy-induced hypertensive women].
    Li AQ; Zhang ZJ
    Zhonghua Fu Chan Ke Za Zhi; 1993 Mar; 28(3):133-5, 187. PubMed ID: 8354089
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Studies on serum digoxin levels under administration of the Kyushin].
    Fushimi R; Tsujimura K; Yasuhara M; Iyama S; Kou T; Motoi S; Khoda K; Hayashi C; Tachi J; Amino N
    Rinsho Byori; 1988 Sep; 36(9):1090-4. PubMed ID: 3246744
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of storage temperature on concentrations of digoxin-like immunoreactive factor(s) in plasma.
    Krivoy N; Jakobi P
    Clin Chem; 1989 May; 35(5):895-6. PubMed ID: 2720993
    [No Abstract]   [Full Text] [Related]  

  • 58. Digoxin-like immunoreactive factor and respiratory distress syndrome.
    Goodlin RC
    Am J Obstet Gynecol; 1990 Sep; 163(3):1091. PubMed ID: 2403136
    [No Abstract]   [Full Text] [Related]  

  • 59. Digoxin-like immunoreactivity, endogenous cardiac glycoside-like factor(s) and natriuretic hormone: more than a hypothesis.
    Clerico A
    J Nucl Med Allied Sci; 1987; 31(4):341-56. PubMed ID: 2832557
    [No Abstract]   [Full Text] [Related]  

  • 60. [Observations on serum digoxin-like immunoreactive substances in patients with cor-pulmonale].
    Shi YS; Liu JH; Yu XZ
    Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(4):229-31. PubMed ID: 8156846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.